A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

Masashi Kanai, Kenichi Yoshimura, Masanori Asada, +12

Cancer Chemotherapy and Pharmacology

Pancreatic CancerPhase I/ii StudyMedicinePharmacologyGemcitabine-based Chemotherapy +5

Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma

Naoshi Nishida, Takeshi Nagasaka, Takafumi Nishimura, +3

Hepatology

A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients

Masashi Kanai, Yoshihiko Otsuka, Kazunori Otsuka, +12

Cancer Chemotherapy and Pharmacology

Pharmaceutical ScienceOncologyMedicinePharmacotherapyBioavailable Curcumin +5

Neutrophil‐to‐lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients

Peng Xue, Masashi Kanai, Yukiko Mori, +8

Cancer Medicine

Disruption of the p16/Cyclin D1/Retinoblastoma Protein Pathway in the Majority of Human Hepatocellular Carcinomas

Hidemasa Azechi, Naoshi Nishida, Yoshihiro Fukuda, +9

Oncology

UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients

Masahide Onoue, Tomohiro Terada, Masahiko Kobayashi, +9

International Journal of Clinical Oncology

OncologyMedicineGenetic EpidemiologyHuman PolymorphismPathology +8

Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer

Shogo Kumagai, Junko Tokuno, Yuichiro Ueda, +5

Molecular and Clinical Oncology

ThrombosisPrognostic EvaluationSurgical OncologyBlood PlateletMedicine +13

Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma

Shogo Kumagai, Satoshi Marumo, Tsuyoshi Shoji, +6

Lung Cancer

Prognostic EvaluationSurgical OncologyPrognostic ImpactPreoperative Monocyte CountsMedicine +10

Extensive Methylation Is Associated with <i>β-Catenin</i> Mutations in Hepatocellular Carcinoma: Evidence for Two Distinct Pathways of Human Hepatocarcinogenesis

Naoshi Nishida, Takafumi Nishimura, Takeshi Nagasaka, +3

Cancer Research

A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer

Masashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, +20

Cancer Chemotherapy and Pharmacology

Gastrointestinal OncologyMedicineBiliary CancerPathologyMetronomic Chemotherapy +5